• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于慢性移植物抗宿主病诊断的全面 B 细胞表型分析。

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

机构信息

Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada.

Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada.

出版信息

Biol Blood Marrow Transplant. 2019 Mar;25(3):451-458. doi: 10.1016/j.bbmt.2018.11.007. Epub 2018 Nov 14.

DOI:10.1016/j.bbmt.2018.11.007
PMID:30447393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6445755/
Abstract

Previous studies have reported single B cell-related chronic graft-versus-host disease diagnostic (cGVHD) biomarkers, such as B cell-activating factor (BAFF), CD21, and immature B cells, but research on the performance of biomarker combinations and the covariate effect of steroids is lacking. The primary objective of this study was to determine the most accurate combination of B cell populations using cell surface staining flow cytometry in an independent cohort of patients with cGVHD. Secondary objectives included assessing the effect of corticosteroid use at sample collection on the makeup and accuracy of the diagnostic panel and identifying the mechanism underlying low surface expression of BAFF receptor (BAFF-R) on B cells in cGVHD. Flow cytometry analysis was performed in an adult cohort of post-HCT patients with cGVHD onset (n = 44) and time-matched recipients without cGVHD (n = 63). We confirmed that the onset of cGVHD was associated with higher soluble BAFF (sBAFF) levels, elevated CD27CD10CD21 CD19 B cell and classical switched memory B cell counts, and reduced transitional and naïve B cell counts. The highest single B cell population area under the receiver operating characteristic (ROC) curve (AUC) was .72 for transitional type 1 CD21 B cells. We also showed a significant inverse relationship between sBAFF and surface BAFF-R expression caused by sBAFF modulation of BAFF-R. Steroid use at sample collection influenced the significance of the sBAFF:B cell ratio, naïve and marginal zone-like B cells. The optimal combination of B cell subsets most significantly associated with cGVHD onset with or without concurrent corticosteroid use resulted in ROC AUCs of .87 and .84, respectively. Transitional and CD21 B cells were the only populations present in both panels; however, analyzing only these populations resulted in ROC AUCs of .79 and .78, respectively. This suggests that the inclusion of other populations and use of different panels depending on steroid use is necessary to achieve better accuracy. sBAFF was not a component of either panel. These novel B cell profiles could be tested prospectively in patients post-HSCT and could lead to focused mechanistic studies.

摘要

先前的研究报告了单一 B 细胞相关的慢性移植物抗宿主病诊断(cGVHD)生物标志物,如 B 细胞激活因子(BAFF)、CD21 和未成熟 B 细胞,但关于生物标志物组合的性能和类固醇的协变量效应的研究尚缺乏。本研究的主要目的是在另一组 cGVHD 患者中使用细胞表面染色流式细胞术确定最准确的 B 细胞群体组合。次要目标包括评估在样本采集时使用皮质类固醇对诊断面板的组成和准确性的影响,以及确定 cGVHD 中 BAFF 受体(BAFF-R)在 B 细胞表面低表达的机制。在一组发生 cGVHD 的成人移植后患者队列(n=44)和时间匹配的无 cGVHD 接受者(n=63)中进行了流式细胞术分析。我们证实 cGVHD 的发生与可溶性 BAFF(sBAFF)水平升高、CD27CD10CD21 CD19 B 细胞和经典转换记忆 B 细胞计数升高以及过渡性和幼稚 B 细胞计数降低有关。单一 B 细胞群体受试者工作特征(ROC)曲线下面积(AUC)最高的是 1 型转换性 CD21 B 细胞,为 0.72。我们还表明,由于 sBAFF 对 BAFF-R 的调节,sBAFF 与表面 BAFF-R 表达之间存在显著的负相关关系。在样本采集时使用类固醇会影响 sBAFF:B 细胞比值、幼稚和边缘区样 B 细胞的意义。在伴有或不伴有皮质类固醇使用的情况下,与 cGVHD 发生最显著相关的 B 细胞亚群的最佳组合导致 ROC AUC 分别为 0.87 和 0.84。过渡性和 CD21 B 细胞是两个面板中都存在的唯一群体;然而,仅分析这些群体导致 ROC AUC 分别为 0.79 和 0.78。这表明需要根据类固醇的使用情况包含其他群体和使用不同的面板,以达到更好的准确性。sBAFF 不是两个面板中的一个组成部分。这些新的 B 细胞谱可以在移植后患者中进行前瞻性测试,并可能导致有针对性的机制研究。

相似文献

1
Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.用于慢性移植物抗宿主病诊断的全面 B 细胞表型分析。
Biol Blood Marrow Transplant. 2019 Mar;25(3):451-458. doi: 10.1016/j.bbmt.2018.11.007. Epub 2018 Nov 14.
2
Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.未成熟/过渡性CD21⁻ B淋巴细胞数量升高以及记忆性CD27⁺ B细胞缺乏可识别出患有活动性慢性移植物抗宿主病的患者。
Biol Blood Marrow Transplant. 2008 Feb;14(2):208-19. doi: 10.1016/j.bbmt.2007.10.009.
3
CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.CD19(+)CD21(low) B 细胞与具有细支气管炎性闭塞综合征的 NIH 定义的慢性移植物抗宿主病风险患者。
Blood. 2013 Mar 7;121(10):1886-95. doi: 10.1182/blood-2012-06-435008. Epub 2013 Jan 9.
4
CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.CD19+CD21低表达B细胞和CD4+CD45RA+CD31+ T细胞与慢性移植物抗宿主病的首次诊断相关。
Biol Blood Marrow Transplant. 2015 Feb;21(2):250-8. doi: 10.1016/j.bbmt.2014.11.010. Epub 2014 Nov 20.
5
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.移植后B细胞活化因子与慢性移植物抗宿主病发作前的B细胞恢复
Biol Blood Marrow Transplant. 2014 May;20(5):668-75. doi: 10.1016/j.bbmt.2014.01.021. Epub 2014 Jan 23.
6
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.人类慢性移植物抗宿主病中B细胞稳态改变与BAFF过量
Blood. 2009 Apr 16;113(16):3865-74. doi: 10.1182/blood-2008-09-177840. Epub 2009 Jan 23.
7
National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.国家卫生研究院定义的儿童造血干细胞移植患者慢性移植物抗宿主病与长期免疫重建的参数相关。
Front Immunol. 2019 Aug 27;10:1879. doi: 10.3389/fimmu.2019.01879. eCollection 2019.
8
Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.B 细胞亚群的显著差异是慢性移植物抗宿主病相关低丙种球蛋白血症患者的特征。
Blood. 2011 Feb 17;117(7):2265-74. doi: 10.1182/blood-2010-07-295766. Epub 2010 Nov 9.
9
Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.间充质基质细胞治疗后慢性移植物抗宿主病患者中幼稚和记忆B细胞亚群的改变。
Stem Cells Transl Med. 2014 Sep;3(9):1023-31. doi: 10.5966/sctm.2014-0001. Epub 2014 Jul 10.
10
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.移植期 B 细胞激活因子水平升高与清髓性异基因造血干细胞移植后急性移植物抗宿主病发生率降低有关。
Biol Blood Marrow Transplant. 2010 May;16(5):629-38. doi: 10.1016/j.bbmt.2009.11.023. Epub 2009 Dec 4.

引用本文的文献

1
Lung transplantation for pulmonary chronic graft-versus-host disease: a missed opportunity?肺移植治疗肺部慢性移植物抗宿主病:一个被错失的机会?
JHLT Open. 2025 Jan 28;7:100209. doi: 10.1016/j.jhlto.2025.100209. eCollection 2025 Feb.
2
Therapeutic efficacy of rituximab combined with cyclosporin A on B-cell dysregulation in chronic graft-versus-host disease.利妥昔单抗联合环孢素A治疗慢性移植物抗宿主病B细胞失调的疗效
Clin Transl Oncol. 2025 Apr;27(4):1789-1797. doi: 10.1007/s12094-024-03684-1. Epub 2024 Sep 4.
3
Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?

本文引用的文献

1
Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease.慢性移植物抗宿主病中B细胞耗竭的证据。
Front Immunol. 2018 Jan 12;8:1937. doi: 10.3389/fimmu.2017.01937. eCollection 2017.
2
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.伊布替尼用于既往治疗失败后的慢性移植物抗宿主病。
Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18.
3
Reversion of anergy signatures in clonal CD21 B cells of mixed cryoglobulinemia after clearance of HCV viremia.
移植物抗宿主病:生物标志物能否辅助鉴别诊断、预后评估及治疗策略制定?
Pharmaceuticals (Basel). 2024 Feb 26;17(3):298. doi: 10.3390/ph17030298.
4
Regulatory B Cells-Immunopathological and Prognostic Potential in Humans.调节性 B 细胞——人类的免疫病理学和预后潜能。
Cells. 2024 Feb 18;13(4):357. doi: 10.3390/cells13040357.
5
Complex interactions of cellular players in chronic Graft-versus-Host Disease.慢性移植物抗宿主病中细胞成分的复杂相互作用。
Front Immunol. 2023 Jun 26;14:1199422. doi: 10.3389/fimmu.2023.1199422. eCollection 2023.
6
Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review.使用 NIH 共识标准进行慢性移植物抗宿主病的细胞和可溶性生物标志物研究:系统评价。
Front Immunol. 2022 Oct 25;13:1033263. doi: 10.3389/fimmu.2022.1033263. eCollection 2022.
7
Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.移植物抗宿主病生物标志物的当前定义和临床意义。
Transplant Cell Ther. 2022 Oct;28(10):657-666. doi: 10.1016/j.jtct.2022.07.008. Epub 2022 Jul 11.
8
Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation.异基因造血干细胞移植后小儿急性淋巴细胞白血病患者长期随访期间自身抗体表达的价值
Front Pediatr. 2021 Dec 21;9:788360. doi: 10.3389/fped.2021.788360. eCollection 2021.
9
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.基于免疫重建的慢性移植物抗宿主病患者风险分层评分
Front Oncol. 2021 Jul 22;11:705568. doi: 10.3389/fonc.2021.705568. eCollection 2021.
10
Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease.芦可替尼作为挽救治疗类固醇难治性慢性移植物抗宿主病的疗效和毒性。
Front Immunol. 2021 Jun 30;12:673636. doi: 10.3389/fimmu.2021.673636. eCollection 2021.
清除 HCV 病毒血症后混合性冷球蛋白血症克隆性 CD21+B 细胞中无反应性特征的逆转。
Blood. 2017 Jul 6;130(1):35-38. doi: 10.1182/blood-2017-03-771238. Epub 2017 May 15.
4
High SYK Expression Drives Constitutive Activation of CD21 B Cells.高SYK表达驱动CD21 B细胞的组成性激活。
J Immunol. 2017 Jun 1;198(11):4285-4292. doi: 10.4049/jimmunol.1700079. Epub 2017 May 3.
5
BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells.ADAM蛋白酶对BAFFR的BAFF和TACI依赖性加工调控B细胞存活
Cell Rep. 2017 Feb 28;18(9):2189-2202. doi: 10.1016/j.celrep.2017.02.005.
6
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.慢性移植物抗宿主病生物标志物的异质性:与CXCL10和CXCR3 +自然杀伤细胞的关联
Blood. 2016 Jun 16;127(24):3082-91. doi: 10.1182/blood-2015-09-668251. Epub 2016 Mar 28.
7
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus.浆细胞样树突状细胞与调节性B细胞之间的调节反馈在系统性红斑狼疮中异常。
Immunity. 2016 Mar 15;44(3):683-697. doi: 10.1016/j.immuni.2016.02.012. Epub 2016 Mar 8.
8
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?异基因造血细胞移植中的浆细胞样树突状细胞:是福还是祸?
Bone Marrow Transplant. 2016 Mar;51(3):333-43. doi: 10.1038/bmt.2015.301. Epub 2015 Dec 7.
9
CD21 -/low B cells: A Snapshot of a Unique B Cell Subset in Health and Disease.CD21低表达/缺失的B细胞:健康与疾病中独特B细胞亚群的概述
Scand J Immunol. 2015 Sep;82(3):254-61. doi: 10.1111/sji.12339.
10
CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.CD19+CD21低表达B细胞和CD4+CD45RA+CD31+ T细胞与慢性移植物抗宿主病的首次诊断相关。
Biol Blood Marrow Transplant. 2015 Feb;21(2):250-8. doi: 10.1016/j.bbmt.2014.11.010. Epub 2014 Nov 20.